A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer

Clinical trial NCT06840535 · COMPLETED

Trial details

NCT number: NCT06840535
Sponsor: Philogen S.p.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Prostate Cancer Metastatic Disease PSA Level Greater Than 0.2

Start date: 2025-04-08
Primary completion: 2025-10-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.